Tinea: Clinical Trials

27 trials for Tinea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed. 27 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 127Completed 27
Phase 22Completed 2

Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Swift Microwave Device for Onychomycosis
Swift Microwave treatment - weekly x 4wks, Swift Microwave treatment - Every other week x 4wks, Swift Microwave treatment - Every other week x 24wks - Onychomycosis of Toenail
Phase 1 / Phase 2CompletedMediprobe Research Inc.392023-03-272024-11-18
A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis
ATB1651, 2 mg/mL, ATB1651, 5 mg/mL, ATB1651, 10 mg/mL - Onychomycosis
Phase 1CompletedAmtixBio Co., Ltd.302022-03-042023-10-11
Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis
itraconazole, terbinafine - Onychomycosis
Phase 1CompletedCombined Military Hospital Abbottabad1002022-03-012022-10-19
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
UHE-103 Cream, Naftin (naftifine hydrochloride) Cream - Tinea Cruris, Tinea Pedis
Phase 1CompletedTherapeutics, Inc.422022-02-172024-04-10
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis
SKX-16 (Luliconazole 10% Solution) - Onychomycosis of Toenail
Phase 1CompletedSATO Pharmaceutical Co., Ltd.192021-09-222026-08-21
Alpha-bisabolol for Onychomycosis Treatment
Drug recommended by the Brazilian Society of Dermatology, Alpha bisabolol product and laser, Alpha bisabolol product - Onychomycosis
Phase 1CompletedUniversidade do Vale do Sapucai602020-06-012021-06-30
Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions
Griseofulvin 500 mg, Griseofulvin 250 mg, Reference Griseofulvin 500 mg - Antifungal Agents
Phase 1CompletedGlaxoSmithKline362020-01-132020-12-28
Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel
Oxiconazole Nitrate Cream 1%, Oxiconazole nitrate SLNs loaded gel. - Tinea
Phase 1CompletedMinia University282018-07-162019-01-30
A Study of the Systemic Absorption of MOB015B
MOB015B - Onychomycosis
Phase 1CompletedMoberg Pharma AB202017-12-162018-05-03
Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis
Naftifine Hydrochloride Gel 2%, Naftin® Gel 2%, Placebo Topical Gel - Tinea Pedis
Phase 1CompletedSun Pharmaceutical Industries, Inc.15192014-06-272018-09-06
Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis
Naftifine Hydrochloride Cream 2%, Naftin® (Naftifine Hydrochloride) Cream 2%, Placebo Topical Cream - Tinea Pedis
Phase 1CompletedSun Pharmaceutical Industries, Inc.8902013-08-012017-05-09
Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
ME1111 solution, Vehicle Solution - Onychomycosis
Phase 1CompletedMeiji Seika Pharma Co., Ltd.242013-03-012013-12-17
Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis
Naftifine HCl Cream 1%, Naftin® (Naftifine HCl) Cream 1%, Placebo topical cream - Tinea Pedis
Phase 1CompletedSun Pharmaceutical Industries, Inc.10532012-05-012014-05-06
Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis
Anti-fungal agent (Clotrimazole) loaded microcapsules, Placebo - Tinea Pedis
Phase 1CompletedProf. Yuen Chun-Wah422012-01-012013-04-02
Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis
Butenafine Hydrochloride Cream, 1%, Lotrimin Ultra®, Butenafine Vehicle - Tinea Pedis
Phase 1CompletedSun Pharmaceutical Industries, Inc.7072012-01-012017-05-05
1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
Laser treatment - Fungal Nail Infection
Phase 1CompletedUniversity of California, Irvine102011-12-012022-11-01
A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis
Oxiconazole Nitrate Cream 1%, Oxiconazole Nitrate Cream 1% (Oxistat®), Placebo - Tinea Pedis
Phase 1CompletedSun Pharmaceutical Industries, Inc.6612011-11-012014-01-22
Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis
Luliconazole Solution, 10% - Onychomycosis
Phase 1 / Phase 2CompletedTopica Pharmaceuticals242010-12-012014-11-26
A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule
Albaconazole tablet 400mg, Albaconazole 100mg capsules, then albaconazole 400mg tablet - Onychomycosis
Phase 1CompletedStiefel, a GSK Company402009-11-232017-06-22
A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus
Albaconozole, Placebo - Onychomycosis
Phase 1CompletedStiefel, a GSK Company242009-08-242017-06-20

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Onychomycosis (15)  ·  Tinea Pedis (11)  ·  Mycoses (1)  ·  Onycholysis (1)  ·  Tinea Cruris (1)

Broader conditions

Bacterial Infections and Mycoses (27)  ·  Dermatomycoses (27)  ·  Infections (27)  ·  Skin Diseases (27)  ·  Skin Diseases, Infectious (27)  ·  Skin and Connective Tissue Diseases (27)  ·  Mycoses (26)  ·  Nail Diseases (15)  ·  Foot Dermatoses (11)  ·  Foot Diseases (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Pruritus (11)  ·  Signs and Symptoms (11)  ·  Skin Manifestations (11)

Interventions

naftifine (4)  ·  Sodium Dodecyl Sulfate (2)  ·  Tablets (2)  ·  Terbinafine (2)  ·  butenafine (2)  ·  Capsules (1)  ·  Clotrimazole (1)  ·  Griseofulvin (1)  ·  Itraconazole (1)  ·  Laser Therapy (1)  ·  Lasers (1)  ·  Solutions (1)  ·  albaconazole (1)  ·  luliconazole (1)  ·  oxiconazole (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (6)  ·  Stiefel, a GSK Company (3)  ·  Pfizer (2)  ·  AmtixBio Co., Ltd. (1)  ·  Combined Military Hospital Abbottabad (1)  ·  Galderma R&D (1)  ·  GlaxoSmithKline (1)  ·  Mediprobe Research Inc. (1)  ·  Meiji Seika Pharma Co., Ltd. (1)  ·  Minia University (1)  ·  Moberg Pharma AB (1)  ·  NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) (1)  ·  Prof. Yuen Chun-Wah (1)  ·  SATO Pharmaceutical Co., Ltd. (1)  ·  Therapeutics, Inc. (1)

Countries

United States (15)  ·  Australia (1)  ·  Belize (1)  ·  Brazil (1)  ·  Canada (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  India (1)  ·  New Zealand (1)  ·  Pakistan (1)

Top investigators

Aditya Gupta, MD,PhD (1)  ·  Alexa B. Kimball, MD, MPH (1)  ·  Brent Clary, CCRC (1)  ·  Chun Wah M. Yuen (1)  ·  Craig Sprenger, MD (1)  ·  David Gratton, MD (1)  ·  Debra Breneman, MD (1)  ·  Eduardo Tschen, MD (1)  ·  Eric M Morrel, PhD (1)  ·  Heba F Mansour, Ph.D (1)  ·  Joseph Fowler, MD (1)

Results publications

PMID 25357174, PMID 39158295, PMID 39624747